Literature DB >> 10744726

Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4.

C Rio1, J D Buxbaum, J J Peschon, G Corfas.   

Abstract

HER4 is a member of the epidermal growth factor receptor family and has an essential function in heart and neural development. Identification of two HER4 isoforms, HER4 JM-a and JM-b, which differ in their extracellular juxtamembrane region and in their susceptibility to cleavage after phorbol ester stimulation, showed that the juxtamembrane region of the receptor is critical for proteolysis. We now demonstrate that phorbol ester and pervanadate are effective stimuli for HER4 JM-a processing and that the HER4 JM-b isoform does not undergo cleavage in response to any of the stimuli studied. We also show that HER4 JM-a is not cleaved in cells lacking the metalloprotease tumor necrosis factor-alpha-converting enzyme (TACE) and that reexpression of TACE in these cells restores constitutive and regulated processing of HER4 JM-a. Moreover, we show that the sequence specific to the HER4 JM-a juxtamembrane region is sufficient to confer susceptibility to phorbol 12-myristate 13-acetate-induced cleavage of the HER2 receptor. In conclusion, we provide evidence that TACE is essential for the regulated shedding of the HER4 JM-a receptor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10744726     DOI: 10.1074/jbc.275.14.10379

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  106 in total

Review 1.  ErbB-4: a receptor tyrosine kinase.

Authors:  W Zhou; G Carpenter
Journal:  Inflamm Res       Date:  2002-02       Impact factor: 4.575

2.  ErbB4 modulates tubular cell polarity and lumen diameter during kidney development.

Authors:  Ville Veikkolainen; Florence Naillat; Antti Railo; Lijun Chi; Aki Manninen; Peter Hohenstein; Nick Hastie; Seppo Vainio; Klaus Elenius
Journal:  J Am Soc Nephrol       Date:  2011-11-10       Impact factor: 10.121

3.  Presenilin-1 processing of ErbB4 in fetal type II cells is necessary for control of fetal lung maturation.

Authors:  Kristina Hoeing; Katja Zscheppang; Sana Mujahid; Sandy Murray; MaryAnn V Volpe; Christiane E L Dammann; Heber C Nielsen
Journal:  Biochim Biophys Acta       Date:  2010-12-29

4.  Interaction with ErbB4 promotes hypoxia-inducible factor-1α signaling.

Authors:  Ilkka Paatero; Anne Jokilammi; Pekka T Heikkinen; Kristiina Iljin; Olli-Pekka Kallioniemi; Frank E Jones; Panu M Jaakkola; Klaus Elenius
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

Review 5.  Molecular and cellular mechanisms of ectodomain shedding.

Authors:  Kazutaka Hayashida; Allison H Bartlett; Ye Chen; Pyong Woo Park
Journal:  Anat Rec (Hoboken)       Date:  2010-06       Impact factor: 2.064

Review 6.  ADAM Proteases and Gastrointestinal Function.

Authors:  Jennifer C Jones; Shelly Rustagi; Peter J Dempsey
Journal:  Annu Rev Physiol       Date:  2015-11-19       Impact factor: 19.318

7.  ErbB4 isoforms selectively regulate growth factor induced Madin-Darby canine kidney cell tubulogenesis.

Authors:  Fenghua Zeng; Ming-Zhi Zhang; Amar B Singh; Roy Zent; Raymond C Harris
Journal:  Mol Biol Cell       Date:  2007-08-29       Impact factor: 4.138

8.  Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene.

Authors:  J D Buxbaum; L Georgieva; J J Young; C Plescia; Y Kajiwara; Y Jiang; V Moskvina; N Norton; T Peirce; H Williams; N J Craddock; L Carroll; G Corfas; K L Davis; M J Owen; S Harroch; T Sakurai; M C O'Donovan
Journal:  Mol Psychiatry       Date:  2007-04-17       Impact factor: 15.992

Review 9.  Trafficking of receptor tyrosine kinases to the nucleus.

Authors:  Graham Carpenter; Hong-Jun Liao
Journal:  Exp Cell Res       Date:  2008-10-11       Impact factor: 3.905

10.  Nuclear transit of the intracellular domain of the interferon receptor subunit IFNaR2 requires Stat2 and Irf9.

Authors:  Ashraf El Fiky; Pete Pioli; Arif Azam; Kiwon Yoo; Kent L Nastiuk; John J Krolewski
Journal:  Cell Signal       Date:  2008-03-21       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.